Avecho Biotechnology (ASX: AVE) has recommenced recruitment for the final stage of its Phase III insomnia trial evaluating a Tocopheryl Phosphate Mixture (TPM)-...
Market Samachar is a news aggregator. This article was originally published by smallcaps.com.au. Tap the button above to read the full story on their site.